Beyond Pain Relief: Role of NSAIDs in Reducing Early Embryonic Loss and Improving Fertility in Dairy Cattle

Even when fertilization occurs successfully, many pregnancies fail during early gestation. Fertilization rates may reach 77–90% in dairy cows, yet conception rates fall to 35–45% by days 27–31 after AI, indicating that early embryonic loss is a major reproductive constraint in dairy herds¹. 

For practicing veterinarians, the key clinical question is whether pharmacological intervention can help improve pregnancy survival after insemination. NSAIDs have emerged as potential supportive reproductive tools, but their success depends heavily on timing and clinical indication rather than routine use. 

Early Pregnancy Maintenance — The Biological Balance 

Pregnancy maintenance in cattle depends on coordinated endocrine and uterine signaling. 

Three events are essential: 

• Adequate progesterone secretion from the corpus luteum 

• Timely embryonic signaling via interferon-tau 

• Controlled uterine prostaglandin secretion 

Progesterone prepares the uterus for embryo survival, while interferon-tau, secreted around days 14–16 of gestation, prevents luteolysis by suppressing prostaglandin F2α (PGF2α) secretion¹. 

Premature PGF2α release is one of the most common causes of early luteal regression and pregnancy failure. 

This physiological pathway is why NSAIDs became attractive tools in reproductive management. 

Flunixin Meglumine — Strongest Evidence for Reproductive Support 

Flunixin meglumine is a potent cyclooxygenase inhibitor that suppresses prostaglandin synthesis, particularly luteolytic PGF2α. 

Clinical applications in practice 

The best fertility responses are observed when flunixin is used in assisted reproduction settings: 

• Embryo transfer recipients 

• Stress-sensitive animals 

• Cows requiring uterine manipulation during procedures 

Recipient cows treated with flunixin around embryo transfer have shown improved pregnancy per transfer, likely due to reduced uterine PGF2α release and improved luteal support^1,2. 

Clinical pearl: 
Flunixin is most useful in embryo transfer programs rather than routine AI fertility management. 

Meloxicam — Useful Drug but Not a Fertility Drug 

Meloxicam is a preferential COX-2 inhibitor with longer biological activity than some other NSAIDs. 

Positive clinical effects 

• Reduction in systemic inflammatory response 

• Improved reproductive performance when combined with disease therapy 

• Reduced prostaglandin metabolite concentrations in some studies 

Meloxicam has shown fertility improvement in specific disease contexts, such as mastitis-associated reproductive dysfunction, when used alongside antimicrobial therapy³. 

Limitations 

In healthy animals, fertility benefits are inconsistent. Excess suppression of prostaglandin E2 may impair implantation because PGE2 has luteotropic and implantation-supporting roles. 

Practical guidance: 
Use meloxicam primarily for pain and inflammatory disease management rather than fertility enhancement in healthy cows. 

Aspirin — Low Cost but Low Reproductive Value 

Although aspirin inhibits cyclooxygenase enzymes and reduces prostaglandin metabolites, reproductive outcomes have been inconsistent. 

Large herd studies failed to demonstrate improved pregnancy per AI during heat stress conditions⁴. 

Long-term administration may disrupt normal reproductive hormone balance. 

Clinical message: 
Aspirin should not be recommended as a fertility management strategy in dairy herds. 

Where NSAIDs Actually Make a Difference 

NSAIDs are most useful in targeted clinical situations rather than herd-wide reproductive programs. 

Best candidates for therapy¹ 

• Embryo transfer recipients 

• Cows experiencing uterine inflammation 

• Animals subjected to intense handling stress during reproductive procedures 

Mechanistic explanation 

NSAIDs help by reducing stress-induced PGF2α release, supporting luteal maintenance during the maternal recognition of pregnancy period. 

When NSAIDs Do Not Improve Fertility 

Routine post-AI NSAID administration is not recommended in: 

• Clinically healthy cows 

• Standard AI fertility programs 

• Animals without inflammatory or reproductive pathology 

The main limitation is that NSAIDs suppress both: 

• Luteolytic prostaglandins (PGF2α) 

• Beneficial luteotropic prostaglandins (PGE2) 

This explains the inconsistent fertility outcomes across studies. 

Future Trends in Reproductive Pharmacology¹ 

Future fertility enhancement strategies are likely to focus on: 

• Selective prostaglandin pathway modulation 

• Precision reproductive medicine 

• Targeted therapy rather than blanket herd treatment 

Research is moving toward drugs that can selectively suppress luteolysis without affecting beneficial reproductive signaling pathways. 

Conclusion 

NSAIDs represent a promising but inconsistent tool for improving reproductive efficiency in dairy cattle. Their primary mechanism involves inhibition of PGF2α synthesis, which may help prevent early luteolysis and embryonic loss. Among available NSAIDs, flunixin meglumine and ibuprofen show the most consistent positive effects during embryo transfer and maternal recognition periods. However, indiscriminate use of NSAIDs is not recommended, and targeted pharmacological reproductive management strategies are needed to improve fertility outcomes in dairy cattle. 

References  

1. Spencer JA, Konetchy D, Ahmadzadeh A. Influences of non-steroidal anti-inflammatory drugs on dairy cattle reproductive performance. Applied Animal Science. 2020 Jun 1;36(3):397-406. https://www.sciencedirect.com/science/article/pii/S2590286520300732  

2. Kasimanickam RK, Hall JB, Estill CT, Kastelic JP, Joseph C, Aziz RA, Nak DE. Flunixin meglumine improves pregnancy rate in embryo recipient beef cows with an excitable temperament. Theriogenology. 2018 Feb 1;107:70-7. https://www.academia.edu/download/98902487/j.theriogenology.2017.10.04320230220-1-dx305a.pdf  

3. McDougall S, Abbeloos E, Piepers S, Rao AS, Astiz S, Van Werven T, Statham J, Pérez-Villalobos N. Addition of meloxicam to the treatment of clinical mastitis improves subsequent reproductive performance. Journal of Dairy Science. 2016 Mar 1;99(3):2026-42. https://www.sciencedirect.com/science/article/pii/S0022030216000175  
4. Spencer JA, Carnahan KG, Shafii B, Dalton J, Ahmadzadeh A. Pregnancy per artificial insemination during summer in lactating dairy cows after treatment with aspirin. Animal Reproduction Science. 2020 Jan 1;212:106253. https://doi.org/10.1016/j.anireprosci.2019.106253